Ovarian Epithelial Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Epithelial Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2019-02-20Clinical Trial Update: Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]
Phase 1 trial evaluating metformin hydrochloride with carboplatin and paclitaxel in recurrent ovarian, fallopian tube, or primary peritoneal…
-
CLINICAL_TRIALS trial_result · 2018-08-15Clinical Trial Update: Phase II Study DCVAC/OvCa Plus Carboplatin Gemcitabine Relapsed Platinum (Pt)-Sensitive Epithelial Ovarian Carcinoma [Phase 2]
Phase II study of DCVAC/OvCa with carboplatin and gemcitabine in relapsed platinum-sensitive epithelial ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) [NA]
Completed clinical trial evaluating quality of life and survivorship care for patients undergoing HIPEC for peritoneal cancers.
-
CLINICAL_TRIALS trial_result · 2018-07-02Clinical Trial Update: Bevacizumab With or Without Everolimus in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating bevacizumab with or without everolimus in recurrent ovarian epithelial cancer, fallopian tube cancer, or primary pe…
-
CLINICAL_TRIALS withdrawal · 2017-07-14Clinical Trial Update: Oregovomab With or Without Cyclophosphamide in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Responded to Second-Line Chemotherapy [NA]
A clinical trial evaluating oregovomab with or without cyclophosphamide in Stage III/IV ovarian epithelial cancer, fallopian tube cancer, or…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Cediranib Maleate in Treating Patients With Persistent, Recurrent, or Refractory Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube Cancer [Phase 2]
Phase 2 clinical trial evaluating cediranib maleate in patients with persistent, recurrent, or refractorily advanced ovarian epithelial, fal…
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Phase I Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian Cancer [Phase 1]
A Phase I trial evaluating stereotactic body radiotherapy for metastatic or recurrent platinum-resistant ovarian cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2016-12-14Clinical Trial Update: Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors [Phase 2]
Phase 2 trial update on belinostat for advanced ovarian epithelial cancer, primary peritoneal cancer, fallopian tube cancer, and ovarian low…
-
CLINICAL_TRIALS trial_result · 2015-12-23Clinical Trial Update: Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer [Phase 3]
Phase 3 trial evaluating paclitaxel plus carboplatin with or without topotecan in stage IIB to IV ovarian epithelial cancer. The study also …
-
CLINICAL_TRIALS trial_result · 2015-12-01Clinical Trial Update: Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma [Phase 2]
Phase 2 trial evaluating erlotinib in combination with carboplatin and paclitaxel in ovarian and related cancers. The study has completed an…
-
CLINICAL_TRIALS trial_result · 2015-11-27Clinical Trial Update: Oxaliplatin and Topotecan in Advance Ovarian Cancer [Phase 2]
A Phase 2 trial of oxaliplatin and topotecan in advanced or recurrent ovarian cancer was terminated, with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-11-09Clinical Trial Update: AZD2171 in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer [Phase 2]
This update reports results from a Phase 2 study of cediranib (AZD2171) in patients with recurrent ovarian, fallopian tube, or primary perit…
-
CLINICAL_TRIALS trial_result · 2015-08-04Clinical Trial Update: Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer [Phase 1]
Phase 1 trial evaluating the combination of carboplatin, gemcitabine hydrochloride, and stereotactic body radiation therapy in gynecologic c…
-
CLINICAL_TRIALS trial_result · 2015-07-13Clinical Trial Update: Ixabepilone in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer That Has Not Responded to Previous Chemotherapy [Phase 2]
A Phase 2 trial evaluating ixabepilone for ovarian epithelial cancer and primary peritoneal cancer that progressed after prior chemotherapy …
-
CLINICAL_TRIALS trial_result · 2015-06-11Clinical Trial Update: Lapatinib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal Cancer [Phase 2]
A Phase 2 clinical trial updating on lapatinib for persistent or recurrent ovarian epithelial or peritoneal cancer has completed with result…
-
CLINICAL_TRIALS trial_result · 2015-05-25Clinical Trial Update: SJG-136 in Treating Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer That Did Not Respond to Previous Treatment With Cisplatin or Carboplatin [Phase 2]
Phase 2 trial of SJG-136 in recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer that failed cisplatin/carboplatin was…
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: Bevacizumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial evaluating bevacizumab in patients with persistent or recurrent ovarian epithelial cancer or primary peritoneal cance…
-
CLINICAL_TRIALS research · 2015-05-06Clinical Trial Update: p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer [Phase 2]
This is an update on a Phase 2 clinical trial evaluating a p53 gene therapy for recurrent ovarian epithelial cancer, fallopian tube cancer, …
-
CLINICAL_TRIALS trial_result · 2015-03-11Clinical Trial Update: VEGF Trap and Docetaxel in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating VEGF Trap with docetaxel in persistent or recurrent ovarian epithelial cancer, primary peritoneal cancer, or fall…
-
CLINICAL_TRIALS trial_result · 2015-01-15Clinical Trial Update: Sunitinib Malate in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
A Phase 2 clinical trial evaluating sunitinib malate in patients with recurrent ovarian epithelial cancer, fallopian tube cancer, or primary…
-
CLINICAL_TRIALS trial_result · 2015-01-15Clinical Trial Update: A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer [Phase 1]
A Phase 1 crossover bioequivalence study comparing ATI-0918 and liposomal doxorubicin (DOXIL/CAELYX) in patients with ovarian cancer, sponso…
-
CLINICAL_TRIALS withdrawal · 2014-12-23Clinical Trial Update: Palliative Care in Improving Quality of Life and Symptoms in Patients With Stage III-IV Pancreatic or Ovarian Cancer [NA]
The clinical trial NCT01927393 evaluating palliative care to improve quality of life and symptoms in stage III-IV pancreatic or ovarian canc…
-
CLINICAL_TRIALS trial_result · 2014-11-21Clinical Trial Update: Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma [Phase 2]
Phase 2 trial evaluating Ziv-aflibercept in locally advanced, unresectable, or metastatic gynecologic soft tissue sarcoma has completed with…
-
CLINICAL_TRIALS trial_result · 2014-07-17Clinical Trial Update: A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial update for A6 in treating persistent or recurrent ovarian epithelial cancer, fallopian tube cancer, or primary perito…
-
CLINICAL_TRIALS trial_result · 2014-06-19Clinical Trial Update: Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating a combination of temsirolimus, carboplatin, and paclitaxel in adults with advanced solid tumors, including ovarian …